MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Charts
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
SNN stock logo

SNN

Smith & Nephew plc

$29.22
-0.08
 (-0.27%)
Exchange:  NYSE
Market Cap:  12.27B
Shares Outstanding:  875.101M
Delayed data
Calculate SNN Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Devices
   
CEO:  Deepak S. Nath
Full Time Employees:  18362
Address: 
Building 5 Croxley Park Hatters Lane
Watford
HRT
WD18 8YE
GB
Website:  https://www.smith-nephew.com
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/08/04 — Q2 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue5,549,0005,810,0006,164,000
Gross Profit3,895,0004,079,0004,207,000
EBITDA1,214,0001,335,0001,336,000
Operating Income425,000657,000794,000
Net Income263,000412,000625,000

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets9,987,00010,354,00010,457,000
Total Liabilities4,770,0005,089,0005,168,000
Total Stockholders Equity5,217,0005,265,0005,289,000
Total Debt3,084,0003,321,0003,327,000
Cash and Cash Equivalents302,000619,000557,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow608,000987,0001,288,002.878
Capital Expenditure-427,000-381,000-434,011.868
Free Cash Flow181,000606,000853,991.010
Net Income290,000412,000626,460.544
Net Change in Cash-44,000317,000-61,999.999

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)7,947,134.943Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)8,141,533.653Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)8,038,000Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)1,779,678.005Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)1,823,211.569Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)1,800,026.287Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)1,281,641.701Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)1,322,538.659Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)1,300,758.956Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)4,018,254.592Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)4,116,547.061Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)4,064,198.059Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)2.980Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)3.030Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)2.940Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)4Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)1Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
5.81B  ?P/S
 (TTM)
: 
1.92
?Net Income
 (TTM)
: 
412M  ?P/E
 (TTM)
: 
19.19
?Enterprise Value
 (TTM)
: 
15.298B  ?EV/FCF
 (TTM)
: 
18.06
?Dividend Yield
 (TTM)
: 
2.72%  ?Payout Ratio
 (TTM)
: 
52.32%
?ROE
 (TTM)
: 
12.25%  ?ROIC
 (TTM)
: 
8.85%
?Net Debt
 (TTM)
: 
2.702B  ?Debt/Equity
 (TTM)
: 
0.73
?P/B
 (TTM)
: 
2.38  ?Current Ratio
 (TTM)
: 
2.14

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
13.04Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about SNN valuation

Is Smith & Nephew plc (SNN) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Smith & Nephew plc (SNN) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is SNN a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether SNN trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is SNN’s P/E ratio?

You can see SNN’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for SNN?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is SNN a good long-term investment?

Whether SNN fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

SNN

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-0.27
MARKETSnap

Trading Metrics:

Open: 29.14   Previous Close: 29.3
Day Low: 29.04   Day High: 29.34
Year Low: 28.56   Year High: 38.79
Price Avg 50: 30.26   Price Avg 200: 32.16
Volume: 697109   Average Volume: 1.42M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

SNN Advances Surgical Robotics Through Imperial College Partnership
19-08-2026 14:00
SNN Advances Surgical Robotics Through Imperial College Partnership
New German expert consensus highlights role for NPWT in mitigating the economic impact of postoperative wound complications
09-07-2026 02:00
New German expert consensus highlights role for NPWT in mitigating the economic impact of postoperative wound complications
New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions
09-07-2026 02:00
New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions
UK's Smith+Nephew keeps annual outlook, plans share buyback as quarterly revenue rises
06-05-2026 02:21
UK's Smith+Nephew keeps annual outlook, plans share buyback as quarterly revenue rises

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Philosophy
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlist & Portfolio Watchlist & Portfolio
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read